Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Algorithm for Glycemic Control in Acute Coronary Syndrome
NCT01151176Phase 4Suspended
- Sponsor
- Universidade Positivo
- Start
- Aug 2012
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of human insulin in acute coronary syndrome (ACS) and hyperglycemia (2 arms), sponsored by Universidade Positivo. Primary endpoint: Differences in daily blood glucose mean concentration between treatment groups at 18 months. Started Aug 2012; status: suspended.
02
Drugs
human insulin
03
Conditions
acute coronary syndrome (ACS)hyperglycemia
Beyond the preview
Go deeper on NCT01151176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151176.